Welcome Guest User | Login or Register

Investor Relations

Investor Relations

STERIS plc is a leading provider of infection prevention and procedural surgical products and services, focused primarily on the critical markets of healthcare, pharmaceutical and research and medical device companies. Our mission is to provide a healthier today and a safer tomorrow through knowledgeable people and innovative infection prevention, decontamination and health science technologies, products and services.

NYSE   |   STE (common stock)
$90.790.00
Stock chart for: STE.  Currently trading at $90.79 with a 52 week high of $91.18 and a 52 week low of $63.80.
10/17/17 4:02 p.m. ET
Data provided by Nasdaq. Minimum 15 minutes delayed.

Recent Press Releases

STERIS Announces Financial Results for Fiscal 2018 First Quarter

Read More

STERIS to Announce Fiscal 2018 First Quarter Financial Results on August 8, 2017

Read More

STERIS Announces Financial Results for Fiscal 2017 Fourth Quarter and Full Year

Read More

Investor Events

Tuesday, August 8, 2017 
10:00 a.m. ET
Q1 2018 STERIS plc Earnings Conference Call
Tuesday, May 9, 2017 
10:00 a.m. ET
Q4 2017 STERIS plc Earnings Conference Call